Our studies demonstrate that, whereas steatosis and resultant increases in mitochondrial ROS drove NOX4 expression in NAFL, the progression toward more advanced disease with fibrosis was accompanied by reduced NOX4 and concomitantly reduced antioxidant defense. The gene discussed is NOX4; the disease is non-alcoholic fatty liver.